ArticleWorld journal of urology2025
Benefits of enhanced recovery after surgery in robotic nephrectomy.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Remote robot-assisted renal surgery: a systematic review and single-arm meta-analysis of real-world evidence.Journal of robotic surgery · 2026Pooled it
- Enhanced recovery after surgery in robot-assisted renal surgery: a systematic review and meta-analysis.Journal of robotic surgery · 2026Pooled it
- Enhanced Recovery After Surgery (ERAS) and Surgical Site Infections (SSIs).Antibiotics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeEnhanced recovery after surgery (ERAS) is an evidence-based perioperative care approach aimed at attenuating surgical stress response and facilitating patient recovery. This study compared postoperative outcomes between an ERAS perioperative model to a traditional, unstandardized perioperative care practice in patients undergoing robotic nephrectomy. MATERIALS AND
methodsA total of 206 patients who underwent robotic renal surgery were stratified into traditional and ERAS cohorts. In total, 111 patients received the ERAS pathway, and 95 received traditional care. Data was collected through a retrospective review of electronic medical records. The primary outcome was length of hospital stay (LOS). The secondary outcomes included patient recovery milestones, pain scores, opioid use, patient complications, 30-day readmission rates, incidence of surgical site infection, and total hospital costs.
resultsImplementation of the ERAS pathway was associated with shorter hospital stay (median LOS 2.2 days vs. 2.3 days p = 0.011), lower post-operative pain scores and lower total opioid requirements at all analyzed time points (0-1, 1-24, and 24-48 h). No statistically significant differences were observed in adverse events, rates of ileus, time to first flatus, surgical site infection, or oral intake. Hospital costs were similar between groups. 30-day readmission was higher in the traditional care cohort (9% vs. 2% p = 0.035).
conclusionsERAS was associated with reduced length of hospital stay, improved pain scores, reduced opioid use, and lower incidence of hospital readmission in patients undergoing robotic nephrectomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.